Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report

INTRODUCTION: Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 μg/kg/h administered for up to 24 hours. Higher dose rates and longer infusion periods are somet...

Descripción completa

Detalles Bibliográficos
Autores principales: Iirola, Timo, Laitio, Ruut, Kentala, Erkki, Aantaa, Riku, Kurvinen, Juha-Pekka, Scheinin, Mika, Olkkola, Klaus T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848065/
https://www.ncbi.nlm.nih.gov/pubmed/20184754
http://dx.doi.org/10.1186/1752-1947-4-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848065/
https://www.ncbi.nlm.nih.gov/pubmed/20184754
http://dx.doi.org/10.1186/1752-1947-4-73

Ejemplares similares